Readmission Risk of Patients With Heart Failure.

Chronic Heart Failure Clinical Trial

— PREDIC  

Official title:

Predicting the Risk of Readmission in Patients With Chronic Heart Failure

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04984928
• Other study ID #: RECHMPL21_0488
• Status: Recruiting
• Start date: September 20, 2021
• Est. completion date: December 30, 2022

Study information

• Verified date: April 2022
• Source: University Hospital, Montpellier
• Contact: Grégoire Mercier, PU PH
• Phone: 4 67 33 91 09
• Email: g-mercier[@]chu-montpellier.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Heart failure (HF) is a frequent, serious, and costly chronic disease: it leads to 150,000 hospitalizations each year in France at a cost of 525 million Euros.

It is estimated that 20-40% of these hospitalizations are preventable by known interventions:

home telemonitoring, care coordination, therapeutic intensification and therapeutic education. But these interventions only work if patients at high risk of rehospitalization are targeted to individualize management. In these patients, the risk of rehospitalization depends on clinical, biological, socioeconomic, care pathway, and location-related data. Existing predictive tools perform poorly due to three important limitations: non-use of unstructured clinical data, lack of integration of multimodal data, and weakness of the algorithmic approach.

The objective is to design and validate a predictive algorithm for the risk of rehospitalization in heart failure patients, using multiple data sources

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 1500
• Est. completion date: December 30, 2022
• Est. primary completion date: December 1, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion criteria:

• All consecutive adults

• Admitted to Montpellier University Hospital in 2017-2020

• For heart failure

Exclusion criteria:

• age < 18 years

Related Conditions & MeSH terms

• Chronic Heart Failure
• Heart Failure

Locations

Country	Name	City	State
France	Uh Montpellier	Montpellier

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	30 days all cause readmission rate	30 days all cause readmission rate	day 30
Secondary	90 days all cause readmission rate	90 days all cause readmission rate	day 90